Product Use Citations
-
Wang Z, et al. HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells
Med Oncol. 2016, 33(5):50.
CAY10603 purchased from Selleck.
-
Zhang O, et al. Atorvastatin promotes human monocyte differentiation toward alternative M2 macrophages through p38 mitogen-activated protein kinase-dependent peroxisome proliferator-activated receptor γ activation.
Int Immunopharmacol. 2015, 26(1):58-64.
T0070907 purchased from Selleck.
-
Deng H, et al. Resveratrol Attenuates Aβ25-35 Caused Neurotoxicity by Inducing Autophagy Through the TyrRS-PARP1-SIRT1 Signaling Pathway
Neurochem Res. 2016, 41(9):2367-79.
AG-14361 , STF-118804 purchased from Selleck.
-
Su X, et al. Telmisartan attenuates peritoneal fibrosis via peroxisome proliferator-activated receptor-γ activation in rats.
Clin Exp Pharmacol Physiol. 2015, 10.1111/1440-1681.12403.
GW9662 purchased from Selleck.
-
Ding M, et al. The polycomb group protein EZH2 is a novel therapeutic target for cervical cancer.
Clin Exp Pharmacol Physiol. 2015, 10.1111/1440-1681.12382.
GSK343 purchased from Selleck.
-
Wang K, et al. MEK-ERK inhibition potentiates WAY-600-induced anti-cancer efficiency in preclinical hepatocellular carcinoma (HCC) models
Biochem Biophys Res Commun. 2016, 474(2):330-7.
PD98059 , Binimetinib (MEK162, ARRY-162, ARRY-438162) and WAY-600 purchased from Selleck.
-
Zhou Y, et al. Autophagy induction contributes to GDC-0349 resistance in head and neck squamous cell carcinoma (HNSCC) cells
Biochem Biophys Res Commun. 2016, 477(2):174-80.
GDC-0349 purchased from Selleck.
-
Ma ZY, et al. TGF-β1 activates the canonical NF-κB signaling to promote cell survival and proliferation in dystrophic muscle fibroblasts in vitro
Biochem Biophys Res Commun. 2016, 471(4):576-81.
-
Udhane SS, et al. Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesis
Biochem Biophys Res Commun. 2016, 477(4):1005-10.
Galeterone , Abiraterone and TAK-700 (Orteronel) purchased from Selleck.
-
Ju T, et al. Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543
Biochem Biophys Res Commun. 2016, 470(3):728-34.
PF-543 purchased from Selleck.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
AllPage:
Page:
